Clinical trial
Chromium and Insulin Action
NCT00283777 · Pennington Biomedical Research Center, Other · Completed
Key facts
| NCT number | NCT00283777 |
|---|---|
| Title | Chromium and Insulin Action |
| Official title | Effect of Chromium Picolinate on Metabolic and Physiologic Parameters in Type 2 Diabetes |
| Lead sponsor | Pennington Biomedical Research Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | Chromium Picolinate |
| Enrollment | 30 |
| Start date | Aug 1, 1998 |
| Primary completion | Jan 1, 2003 |
| Completion | Apr 1, 2003 |
| First posted | Jan 30, 2006 |
| Last update posted | Apr 8, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: